In recent years, a number of clinical studies have shown that secondary hypopituitarism occurs in patients with moderate-to-severe TBIs, and the reduced GH level is associated with cognitive impairment in these patients [2], [29]–[31]. This evidence concerns the gene GH1 and hypopituitarism.